Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
P&K Skin Research Center
Market Cap: ₩81.4b
Engages in the evaluation and research of dermatological products in South Korea.
A347740
₩2,780.00
7D
-4.1%
1Y
3.5%
Proteomics International Laboratories
Market Cap: AU$52.4m
Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia.
PIQ
AU$0.35
7D
0%
1Y
-50.0%
JW Pharmaceutical
Market Cap: ₩497.4b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩21,150.00
7D
-5.4%
1Y
-25.9%
Yuyu Pharma
Market Cap: ₩68.4b
Develops and markets pharmaceutical products.
A000220
₩4,230.00
7D
-3.3%
1Y
-8.4%
Daiichi Sankyo Company
Market Cap: JP¥6.3t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,344.00
7D
-5.6%
1Y
-31.3%
Zhejiang Yatai Pharmaceutical
Market Cap: CN¥4.2b
Researches, produces, sells, and exports pharmaceutical products in China and internationally.
002370
CN¥5.67
7D
-3.1%
1Y
87.7%
MedPacto
Market Cap: ₩151.5b
A drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea.
A235980
₩4,300.00
7D
-6.3%
1Y
-31.0%
Xcell Therapeutics
Market Cap: ₩34.0b
Engages in the development and production of drugs for cell therapy.
A373110
₩3,005.00
7D
-8.2%
1Y
-63.1%
Sinil Pharmaceutical
Market Cap: ₩70.4b
Manufactures and sells pharmaceutical products in South Korea and internationally.
A012790
₩6,120.00
7D
-2.1%
1Y
-16.6%
Prescient Therapeutics
Market Cap: AU$44.2m
A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.
PTX
AU$0.042
7D
-1.2%
1Y
6.4%
Cisen Pharmaceutical
Market Cap: CN¥9.2b
Research, develops, produces, and sells drug products in China and internationally.
603367
CN¥19.84
7D
-5.0%
1Y
47.9%
Sunflower Pharmaceutical GroupLtd
Market Cap: CN¥9.0b
Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.
002737
CN¥15.40
7D
-1.7%
1Y
-29.1%
Jiangsu Nhwa Pharmaceutical
Market Cap: CN¥29.2b
Engages in production, marketing, and services related to central nervous system drugs in China.
002262
CN¥27.74
7D
1.1%
1Y
11.0%
NatureCellLtd
Market Cap: ₩1.3t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩20,200.00
7D
-3.6%
1Y
108.0%
Harbin Pharmaceutical Group
Market Cap: CN¥8.9b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥3.60
7D
-1.4%
1Y
5.6%
Kringle Pharma
Market Cap: JP¥3.3b
Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.
4884
JP¥467.00
7D
-3.9%
1Y
-45.8%
GC Genome
Market Cap: ₩185.9b
Operates as a clinical genome analysis company in South Korea.
A340450
₩7,510.00
7D
-7.1%
1Y
n/a
China Resources Boya Bio-pharmaceutical GroupLtd
Market Cap: CN¥12.4b
Engages in the blood product businesses in China.
300294
CN¥24.52
7D
-2.0%
1Y
-25.5%
Shanghai InnoStar Bio-tech
Market Cap: CN¥7.0b
Provides drug research and development services in China and internationally.
688710
CN¥47.39
7D
-3.6%
1Y
78.1%
Sinew Pharma
Market Cap: NT$3.4b
A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.
6634
NT$47.40
7D
2.0%
1Y
-25.5%
Takara Bio
Market Cap: JP¥112.9b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥939.00
7D
-1.5%
1Y
-9.9%
Ribomic
Market Cap: JP¥4.2b
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.
4591
JP¥98.00
7D
3.2%
1Y
18.1%
Kissei Pharmaceutical
Market Cap: JP¥184.4b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,455.00
7D
0.2%
1Y
24.8%
Solasia Pharma K.K
Market Cap: JP¥9.5b
Engages in the development and marketing of oncology drugs in Japan and other Asian countries.
4597
JP¥36.00
7D
0%
1Y
-23.4%
ScinoPharm Taiwan
Market Cap: NT$15.2b
Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.
1789
NT$18.85
7D
2.4%
1Y
-25.9%
Peptron
Market Cap: ₩6.6t
Engages in the development of peptide-based medicines.
A087010
₩277,500.00
7D
-4.1%
1Y
418.7%
Alar Pharmaceuticals
Market Cap: NT$14.5b
A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.
6785
NT$213.00
7D
0.7%
1Y
14.5%
RP Bio
Market Cap: ₩62.9b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩7,280.00
7D
4.7%
1Y
9.5%
2invest
Market Cap: €74.4m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€13.50
7D
7.1%
1Y
28.6%
Smart Agro -
Market Cap: ₪9.4m
Focuses on the research and development in the field of agricultural technology in Israel.
SMAG
₪2.25
7D
0%
1Y
-47.5%
Regeneron Pharmaceuticals
Market Cap: US$59.8b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$555.51
7D
-7.2%
1Y
-46.6%
Sanofi
Market Cap: €94.3b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€77.52
7D
-3.3%
1Y
-24.2%
Pharma-Bio Serv
Market Cap: US$13.8m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.60
7D
5.3%
1Y
9.1%
Mustang Bio
Market Cap: US$11.7m
A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.
MBIO
US$1.60
7D
-1.2%
1Y
-86.6%
Devonian Health Group
Market Cap: CA$23.8m
Engages in the development of botanical drugs.
GSD
CA$0.14
7D
-14.7%
1Y
-6.5%
OnKure Therapeutics
Market Cap: US$34.4m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.
OKUR
US$2.54
7D
2.4%
1Y
n/a